Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
alex azar
alliance for aging research
amgen
biogen
biotechnology innovation organization
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
drug pricing
duane schulthess
eli lilly
erica whittaker
fda
indiana blog main
indiana top stories
jim greenwood
life sciences
medicaid
medicare
nancy pelosi
natalizumab
national
national blog main
national top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
regeneron pharmaceuticals
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
startups
susan peschin
What
despite
2
×
plans
2
×
accessing
administration
allegations
angry
anti
benefited
day
drug
employees
executive
fact
fear
feels
frances
frei
future
greyballing
harassment
hasn’t
industry
leadership
live
losing
medical
optimistic
pharma
presidential
price
proud
read
records
rhetoric
rider’s
rx
scalps
seen
sexual
shirt
Language
Current search:
despite
×
plans
×
@xconomy.com
5 years ago
Losing “Scalps”? Despite Pharma Fear, A Split on Trump Rx-Price Plans
@techcrunch.com
6 years ago
Uber’s SVP of leadership and strategy says she hasn’t seen any toxicity
